MEDOVEX, INC. 1,391,305 Units, each consisting of (i) One Share of Common Stock, $0.001 par value; (ii) One Series A Warrant to Purchase One Share of Common Stock, $0.001 par value; and (iii) One Series B Warrant to purchase one share of Common Stock,...Medovex Corp. • December 2nd, 2014 • Surgical & medical instruments & apparatus • New York
Medovex, Inc., a Nevada corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representative (the “Representative”), an aggregate of 1,391,305 units (the “Underwritten Units”) of the Company’s securities. The Company has granted the Underwriters a thirty (30) day option to purchase an aggregate of up to 208,695 additional units (the “Additional Units” and collectively with the Underwritten Units, the “Units”) as may be necessary to cover over-allotments made in connection with the offering. Each Unit consists of one share of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and two warrants (each, a “Series A Warrant and Series B Warrant” and collectively, the “Warrants”). Each Series A Warrant and Series B Warrant entitles the holder to purchase one share of Common Stock. The Units, the shares of Common
